Aclaris Therapeutics, Inc. (ACRS)
NASDAQ·Healthcare·Biotechnology
$5.17
-9.70%
Mkt Cap $768.15M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$10.75
Range $10.00 – $12.00
Implied Upside
+108.1%
Consensus $10.75 vs current $5.17
NASDAQ·Healthcare·Biotechnology
$5.17
-9.70%
Mkt Cap $768.15M
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$10.75
Range $10.00 – $12.00
+108.1%
Consensus $10.75 vs current $5.17